Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inovio Pharmaceuticals

2.27
+0.15007.08%
Post-market: 2.300.0291+1.28%19:51 EDT
Volume:1.17M
Turnover:2.63M
Market Cap:83.25M
PE:-0.73
High:2.33
Open:2.15
Low:2.14
Close:2.12
Loading ...
May 18, 2020

Major Issues Report

8-K - Current report
May 12, 2020

Major Issues Report

8-K - Current report
May 11, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 24, 2020

Correspondence

CORRESP [Cover] - Correspondence
Apr 06, 2020

Major Issues Report

Current report, item 8.01
Apr 03, 2020

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Mar 27, 2020

Correspondence

CORRESP [Cover] - Correspondence
Mar 12, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2020

Major Issues Report

8-K - Current report
Feb 12, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 11, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Correspondence

CORRESP [Cover] - Correspondence
Feb 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Major Issues Report

Current report, items 1.01 and 9.01
Feb 05, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 31, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Jan 15, 2020

Major Issues Report

Current report, items 5.02, 7.01, and 9.01
Jan 02, 2020

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Nov 12, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]